Catalysts for Biocon Pharma Ltd
41 tracked
Feb 8, 2016
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Dec 22, 2015
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Jun 19, 2015
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Feb 11, 2015
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
May 7, 2014
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Mar 26, 2014
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Feb 21, 2014
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Nov 18, 2013
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Nov 8, 2013
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
May 3, 2013
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→
Nov 6, 2012
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
Biocon Pharma Ltd
→